title: Elimination of deleterious effects of DMBA-induced skin carcinogenesis in mice by Syzygium cumini seed extract.
abstract: The inhibition of tumor incidence by hydro-alcoholic extract of S.cumini seed was evaluated in mice on two stage process of skin carcinogenesis induced by single application of 7, 12-dimethyl benz(a)anthracene (100 µg/100µl of acetone), and 2 weeks later promoted by repeated application of croton oil (1% acetone/thrice in a week) till the end of the experiment (i.e. 16 weeks). Oral administration of extract at a dose of 250mg/kg b.wt./day at the peri-initiational stage (i.e. 7 days before and 7 days after DMBA application), promotional stage (i.e. from the time of croton oil application) and at both the stages (i.e. 7 days prior to DMBA application & continued till the end of experiment) to the mice, recorded a significant reduction in tumor incidence to 37.5, 50 & 25% respectively in comparison to the carcinogen treated control, where tumor incidence was found as 100%. Tumor yield and Tumor burden were also significantly reduced by SCE. Similarly, the cumulative number of papillomas after 16 weeks was 68 in the control group, which was reduced to 15, 21 & 8 in the animals treated with the SCE continuously at peri-, post- and peri- & post- initiation stage respectively. A significant impairment was noticed in the levels of reduced glutathione, superoxide dismutase, catalase & protein and enhancement in LPO in liver and skin of carcinogen treated control mice as compared with vehicle treated mice. All such parameters were returned to near normal value by administration of SCE to DMBA treated mice. These results suggest a possible chemopreventive property of S.cumini against DMBA induced skin carcinogenesis in mice.
authors.affiliation: University of Rajasthan, Jaipur, Rajasthan, India.
authors.forename: Jyoti
authors.initials: J
authors.lastname: Parmar
authors.forename: Priyanka
authors.initials: P
authors.lastname: Sharma
authors.forename: Preeti
authors.initials: P
authors.lastname: Verma
authors.forename: Priyanka
authors.initials: P
authors.lastname: Sharma
authors.forename: Pradeep K
authors.initials: PK
authors.lastname: Goyal
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D002273:Carcinogens; D002374:Catalase / Q000378:metabolism; D002471:Cell Transformation, Neoplastic / Q000187:drug effects* / Q000473:pathology; D018890:Chemoprevention / Q000379:methods; D003436:Croton Oil / Q000009:adverse effects; D005978:Glutathione / Q000378:metabolism; D029001:Herbal Medicine / Q000379:methods; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D051379:Mice; D010212:Papilloma / Q000188:drug therapy / Q000473:pathology; D010936:Plant Extracts / Q000494:pharmacology*; D012639:Seeds / Q000737:chemistry*; D012867:Skin / Q000187:drug effects / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D013482:Superoxide Dismutase / Q000378:metabolism; D027842:Syzygium / Q000737:chemistry*
chemical_list: D002273:Carcinogens; D010936:Plant Extracts; D015127:9,10-Dimethyl-1,2-benzanthracene; D003436:Croton Oil; D002374:Catalase; D013482:Superoxide Dismutase; D005978:Glutathione